History & Overview
Annual Report
President's Pages
Center News
Community Affairs
Make a Gift
Yankees Universe Fund
Fred's Team
Cycle for Survival
Thomas Blake Sr. Memorial Research Fund
Donating Blood & Platelets
Volunteering
Thrift Shop
Park Avenue Potluck Cookbook
Press Releases
Information for Journalists
News@MSKCC
Manhattan
New Jersey
Long Island
Westchester
Working at Memorial Sloan-Kettering
Work Sites
College Recruitment
About Nursing
Job Fairs & Career Days
Job Search & Apply Online
David Spriggs
Members of the Laboratory
Projects
NF-KB as Mediator of Drug Resistance
RNA Binding Proteins as Targets of Drug Therapy
MUC16 Signal Transduction
Publications
Research
>
Memorial Hospital Research
>
Memorial Hospital Research Laboratories
>
David Spriggs
>
Projects
>
NF-KB as Mediator of Drug Resistance
Selected Publications
Aghajanian C, Dizon DS, Sabbatini P, Raizer JJ, Dupont J, and Spriggs DR. A Phase I Trial of Bortezomib and Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer. J Clin Oncol. 2005 Sep 1;23(25):5943-9.
Site Map
|
Index
Legal Disclaimer
|
Privacy Practices
|
Public Notices
©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000
1275 York Avenue New York, NY 10065.
PublicAffairs@mskcc.org
